Arcus Biosciences, Inc. - Common Stock (RCUS)
CUSIP: 03969F109
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 122,470,452
- Total 13F shares
- 45,147,112
- Share change
- +420,530
- Total reported value
- $1,239,729,813
- Put/Call ratio
- 400%
- Price per share
- $27.46
- Number of holders
- 125
- Value change
- +$11,589,356
- Number of buys
- 56
- Number of sells
- 75
Quarterly Holders Quick Answers
What is CUSIP 03969F109?
CUSIP 03969F109 identifies RCUS - Arcus Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03969F109:
Top shareholders of RCUS - Arcus Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Alphabet Inc. |
13F
|
Company |
3.9%
|
4,723,348
|
$132,632,000 | — | 31 Mar 2021 | |
| PFM Health Sciences, LP |
13F
|
Company |
2.9%
|
3,498,260
|
$98,231,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.8%
|
3,393,646
|
$95,295,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.1%
|
2,524,849
|
$70,897,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
1.8%
|
2,233,660
|
$62,721,000 | — | 31 Mar 2021 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.8%
|
2,195,892
|
$61,661,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.8%
|
2,165,394
|
$60,804,000 | — | 31 Mar 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
1.7%
|
2,084,883
|
$58,544,000 | — | 31 Mar 2021 | |
| BVF INC/IL |
13F
|
Company |
1.5%
|
1,876,122
|
$52,682,000 | — | 31 Mar 2021 | |
| Invus Financial Advisors, LLC |
13F
|
Company |
1.5%
|
1,842,077
|
$51,726,000 | — | 31 Mar 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.2%
|
1,530,348
|
$42,972,000 | — | 31 Mar 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.1%
|
1,370,395
|
$38,481,000 | — | 31 Mar 2021 | |
| Woodline Partners LP |
13F
|
Company |
1%
|
1,237,730
|
$34,755,000 | — | 31 Mar 2021 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.7%
|
859,210
|
$24,127,000 | — | 31 Mar 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.65%
|
794,822
|
$22,319,000 | — | 31 Mar 2021 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.59%
|
719,540
|
$20,205,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.58%
|
711,522
|
$19,979,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.47%
|
581,451
|
$16,327,000 | — | 31 Mar 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.46%
|
559,309
|
$15,706,000 | — | 31 Mar 2021 | |
| HealthCor Management, L.P. |
13F
|
Company |
0.44%
|
536,970
|
$15,078,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.41%
|
500,846
|
$14,063,000 | — | 31 Mar 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.38%
|
466,400
|
$13,097,000 | — | 31 Mar 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.38%
|
463,398
|
$13,012,000 | — | 31 Mar 2021 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.33%
|
400,000
|
$11,232,000 | — | 31 Mar 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.31%
|
378,023
|
$10,615,000 | — | 31 Mar 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.33%
|
408,977
|
$10,198,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.27%
|
333,271
|
$9,359,000 | — | 31 Mar 2021 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.26%
|
315,882
|
$8,870,000 | — | 31 Mar 2021 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.25%
|
304,212
|
$8,542,000 | — | 31 Mar 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.24%
|
297,877
|
$8,364,000 | — | 31 Mar 2021 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.23%
|
284,526
|
$7,989,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.21%
|
256,900
|
$7,214,000 | — | 31 Mar 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.2%
|
250,000
|
$7,020,000 | — | 31 Mar 2021 | |
| Asymmetry Capital Management, L.P. |
13F
|
Company |
0.19%
|
236,494
|
$6,641,000 | — | 31 Mar 2021 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.18%
|
219,125
|
$6,153,000 | — | 31 Mar 2021 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.16%
|
192,150
|
$5,396,000 | — | 31 Mar 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.15%
|
189,393
|
$5,318,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.14%
|
174,596
|
$4,902,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.14%
|
171,985
|
$4,830,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
169,749
|
$4,767,000 | — | 31 Mar 2021 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.12%
|
141,097
|
$3,962,000 | — | 31 Mar 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.11%
|
137,283
|
$3,855,000 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.11%
|
135,938
|
$3,817,000 | — | 31 Mar 2021 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.1%
|
117,962
|
$3,313,000 | — | 31 Mar 2021 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.1%
|
117,451
|
$3,298,000 | — | 31 Mar 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.1%
|
117,396
|
$3,296,000 | — | 31 Mar 2021 | |
| Swiss National Bank |
13F
|
Company |
0.08%
|
96,496
|
$2,710,000 | — | 31 Mar 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.07%
|
91,402
|
$2,567,000 | — | 31 Mar 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.07%
|
85,700
|
$2,406,000 | — | 31 Mar 2021 | |
| Parallel Advisors, LLC |
13F
|
Company |
0.07%
|
85,225
|
$2,393,000 | — | 31 Mar 2021 |
Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q2 2021
As of 30 Jun 2021,
Arcus Biosciences, Inc. - Common Stock (RCUS) was held by
125 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,147,112 shares.
The largest 10 holders included
Alphabet Inc., BlackRock Inc., PFM Health Sciences, LP, EcoR1 Capital, LLC, FMR LLC, BVF INC/IL, STATE STREET CORP, VANGUARD GROUP INC, BOXER CAPITAL, LLC, and Invus Financial Advisors, LLC.
This page lists
125
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
143
Q2 2021 holders
125
Holder diff
-18
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.